Cargando…
Case Report: Unmanipulated Matched Sibling Donor Hematopoietic Cell Transplantation In TBX1 Congenital Athymia: A Lifesaving Therapeutic Approach When Facing a Systemic Viral Infection
Congenital athymia can present with severe T cell lymphopenia (TCL) in the newborn period, which can be detected by decreased T cell receptor excision circles (TRECs) on newborn screening (NBS). The most common thymic stromal defect causing selective TCL is 22q11.2 deletion syndrome (22q11.2DS). T-b...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794793/ https://www.ncbi.nlm.nih.gov/pubmed/35095830 http://dx.doi.org/10.3389/fimmu.2021.721917 |
_version_ | 1784640900108910592 |
---|---|
author | Chitty-Lopez, Maria Duff, Carla Vaughn, Gretchen Trotter, Jessica Monforte, Hector Lindsay, David Haddad, Elie Keller, Michael D. Oshrine, Benjamin R. Leiding, Jennifer W. |
author_facet | Chitty-Lopez, Maria Duff, Carla Vaughn, Gretchen Trotter, Jessica Monforte, Hector Lindsay, David Haddad, Elie Keller, Michael D. Oshrine, Benjamin R. Leiding, Jennifer W. |
author_sort | Chitty-Lopez, Maria |
collection | PubMed |
description | Congenital athymia can present with severe T cell lymphopenia (TCL) in the newborn period, which can be detected by decreased T cell receptor excision circles (TRECs) on newborn screening (NBS). The most common thymic stromal defect causing selective TCL is 22q11.2 deletion syndrome (22q11.2DS). T-box transcription factor 1 (TBX1), present on chromosome 22, is responsible for thymic epithelial development. Single variants in TBX1 causing haploinsufficiency cause a clinical syndrome that mimics 22q11.2DS. Definitive therapy for congenital athymia is allogeneic thymic transplantation. However, universal availability of such therapy is limited. We present a patient with early diagnosis of congenital athymia due to TBX1 haploinsufficiency. While evaluating for thymic transplantation, she developed Omenn Syndrome (OS) and life-threatening adenoviremia. Despite treatment with anti-virals and cytotoxic T lymphocytes (CTLs), life threatening adenoviremia persisted. Given the imminent need for rapid establishment of T cell immunity and viral clearance, the patient underwent an unmanipulated matched sibling donor (MSD) hematopoietic cell transplant (HCT), ultimately achieving post-thymic donor-derived engraftment, viral clearance, and immune reconstitution. This case illustrates that because of the slower immune recovery that occurs following thymus transplantation and the restricted availability of thymus transplantation globally, clinicians may consider CTL therapy and HCT to treat congenital athymia patients with severe infections. |
format | Online Article Text |
id | pubmed-8794793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87947932022-01-29 Case Report: Unmanipulated Matched Sibling Donor Hematopoietic Cell Transplantation In TBX1 Congenital Athymia: A Lifesaving Therapeutic Approach When Facing a Systemic Viral Infection Chitty-Lopez, Maria Duff, Carla Vaughn, Gretchen Trotter, Jessica Monforte, Hector Lindsay, David Haddad, Elie Keller, Michael D. Oshrine, Benjamin R. Leiding, Jennifer W. Front Immunol Immunology Congenital athymia can present with severe T cell lymphopenia (TCL) in the newborn period, which can be detected by decreased T cell receptor excision circles (TRECs) on newborn screening (NBS). The most common thymic stromal defect causing selective TCL is 22q11.2 deletion syndrome (22q11.2DS). T-box transcription factor 1 (TBX1), present on chromosome 22, is responsible for thymic epithelial development. Single variants in TBX1 causing haploinsufficiency cause a clinical syndrome that mimics 22q11.2DS. Definitive therapy for congenital athymia is allogeneic thymic transplantation. However, universal availability of such therapy is limited. We present a patient with early diagnosis of congenital athymia due to TBX1 haploinsufficiency. While evaluating for thymic transplantation, she developed Omenn Syndrome (OS) and life-threatening adenoviremia. Despite treatment with anti-virals and cytotoxic T lymphocytes (CTLs), life threatening adenoviremia persisted. Given the imminent need for rapid establishment of T cell immunity and viral clearance, the patient underwent an unmanipulated matched sibling donor (MSD) hematopoietic cell transplant (HCT), ultimately achieving post-thymic donor-derived engraftment, viral clearance, and immune reconstitution. This case illustrates that because of the slower immune recovery that occurs following thymus transplantation and the restricted availability of thymus transplantation globally, clinicians may consider CTL therapy and HCT to treat congenital athymia patients with severe infections. Frontiers Media S.A. 2022-01-14 /pmc/articles/PMC8794793/ /pubmed/35095830 http://dx.doi.org/10.3389/fimmu.2021.721917 Text en Copyright © 2022 Chitty-Lopez, Duff, Vaughn, Trotter, Monforte, Lindsay, Haddad, Keller, Oshrine and Leiding https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Chitty-Lopez, Maria Duff, Carla Vaughn, Gretchen Trotter, Jessica Monforte, Hector Lindsay, David Haddad, Elie Keller, Michael D. Oshrine, Benjamin R. Leiding, Jennifer W. Case Report: Unmanipulated Matched Sibling Donor Hematopoietic Cell Transplantation In TBX1 Congenital Athymia: A Lifesaving Therapeutic Approach When Facing a Systemic Viral Infection |
title | Case Report: Unmanipulated Matched Sibling Donor Hematopoietic Cell Transplantation In TBX1 Congenital Athymia: A Lifesaving Therapeutic Approach When Facing a Systemic Viral Infection |
title_full | Case Report: Unmanipulated Matched Sibling Donor Hematopoietic Cell Transplantation In TBX1 Congenital Athymia: A Lifesaving Therapeutic Approach When Facing a Systemic Viral Infection |
title_fullStr | Case Report: Unmanipulated Matched Sibling Donor Hematopoietic Cell Transplantation In TBX1 Congenital Athymia: A Lifesaving Therapeutic Approach When Facing a Systemic Viral Infection |
title_full_unstemmed | Case Report: Unmanipulated Matched Sibling Donor Hematopoietic Cell Transplantation In TBX1 Congenital Athymia: A Lifesaving Therapeutic Approach When Facing a Systemic Viral Infection |
title_short | Case Report: Unmanipulated Matched Sibling Donor Hematopoietic Cell Transplantation In TBX1 Congenital Athymia: A Lifesaving Therapeutic Approach When Facing a Systemic Viral Infection |
title_sort | case report: unmanipulated matched sibling donor hematopoietic cell transplantation in tbx1 congenital athymia: a lifesaving therapeutic approach when facing a systemic viral infection |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794793/ https://www.ncbi.nlm.nih.gov/pubmed/35095830 http://dx.doi.org/10.3389/fimmu.2021.721917 |
work_keys_str_mv | AT chittylopezmaria casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection AT duffcarla casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection AT vaughngretchen casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection AT trotterjessica casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection AT monfortehector casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection AT lindsaydavid casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection AT haddadelie casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection AT kellermichaeld casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection AT oshrinebenjaminr casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection AT leidingjenniferw casereportunmanipulatedmatchedsiblingdonorhematopoieticcelltransplantationintbx1congenitalathymiaalifesavingtherapeuticapproachwhenfacingasystemicviralinfection |